We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

A close up of someone holding a book open in their lap.

Neuro-Cognitive Computer Models Make Reading More Efficient

T cells.

Immune Cells “Remember” the Pain of Newborn Injuries

Nerve Cells in the Human Neocortex Are Wired Differently Than in Mice

Materials Follow the “Rule of Four” — But Scientists Don’t Know Why Yet

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

News

Elevated Hormone Levels Add Up to Increased Breast Cancer Risk

New research found that the risk of breast cancer increased with the high levels of estrogen or testosterone hormones.

YM BioSciences Proposes Dr. Catherine Mackey and Dr. Nicole Onetto for Nomination to Board of Directors

Company announces annual and special meeting of shareholders and appoints new head of strategic alliances.

Metabolomics Insight into Periodontal Disease Published in the Journal of Dental Research

Data reveal altered host-bacteria interactions associated with periodontitis.

Almac Invests £1M in Dedicated Mass Spectrometry Laboratory

Investment increases the company’s capabilities in solving complex analytical challenges.

Thallion Resuming Patient Recruitment in Phase II SHIGATEC Trial

Latest data support the continued use of the original lot of anti-Stx1 antibody for clinical testing.

New UW-Madison CALS Dean Named

Kathryn VandenBosch selected as the new dean of the College of Agricultural and Life Sciences.

Commonly Used Three-Drug Regimen for IPF Found Harmful

NIH stops one treatment arm of trial, other two treatments to continue.

Gyros Announces Changes to its Management Team

Dr. Jon-Sverre Schanche becomes Chief Technology Officer and Vice President Technical Affairs.

GenoLogics Raises $8 Million Strategic Financing Round Led by Illumina

An $8 million Series D round of financing led by new investor Illumina, Inc. has been raised by GenoLogics Life Sciences Software Inc.

Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics

Miragen to receive regulatory and commercial milestones of $352 million and double-digit royalties on product sales in markets outside the U.S. and Japan.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter